Corneal Collagen Cross-Linking Under General Anesthesia for Pediatric Patients With Keratoconus and Developmental

Tessnim R Ahmad1, Neel D Pasricha2, Jennifer Rose-Nussbaumer3,4

  • 1School of Medicine, University of California, San Francisco, San Francisco, CA.

Cornea
|November 15, 2019
PubMed

Insights

Corneal collagen cross-linking (CXL) under general anesthesia is safe and effective for pediatric keratoconus patients with developmental delays, halting disease progression and improving visual outcomes.

Area of Science:

  • Ophthalmology
  • Pediatric Eye Care
  • Corneal Diseases

Background:

  • Keratoconus (KCN) is a progressive corneal ectasia affecting pediatric patients.
  • Developmental delay or inability to cooperate necessitates alternative anesthetic approaches for KCN treatment.
  • Topical anesthesia may be insufficient for certain pediatric populations requiring KCN intervention.

Purpose of the Study:

  • To evaluate the clinical characteristics and outcomes of pediatric KCN patients undergoing corneal collagen cross-linking (CXL) under general anesthesia.
  • To assess the safety and efficacy of CXL in patients with developmental delay or inability to cooperate with topical anesthesia.

Main Methods:

  • Retrospective case series of pediatric KCN patients who underwent CXL under general anesthesia (January 2018 - April 2019).
  • Comparison of baseline characteristics between developmentally delayed and non-delayed patients.
  • Assessment of anesthesia/surgical complications, best corrected visual acuity (BCVA), keratometry (K) values, and eye-rubbing behavior post-operatively.

Main Results:

  • Fourteen eyes of 9 pediatric patients were reviewed; 66.7% had developmental delay.
  • No anesthesia or surgical complications were reported.
  • Postoperative BCVA and K values remained stable at 6 months; 8 patients reduced or stopped eye rubbing.

Conclusions:

  • Corneal collagen cross-linking (CXL) under general anesthesia is a safe and effective treatment for pediatric keratoconus.
  • This approach successfully halts KCN progression in patients with developmental delay or cooperation challenges.
  • CXL under general anesthesia offers a viable solution for managing KCN in non-cooperative pediatric populations.
Abstract